Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2021
Sep. 30, 2022
Cash flows from Operating Activities:        
Net income     $ 10,213,405 $ 62,234
Adjustments to reconcile net income to net cash used in operating activities:        
Offering expenses related to warrant issuance   $ 2,024,525 2,024,525  
Excess value of Private Placement Warrants   1,066,666 1,066,666  
Interest earned on marketable securities held in Trust Account $ (1,173,324) (2,491) (2,491) (1,538,074)
Change in fair value of warrants (2,588,610) (13,400,065) (13,400,065) (3,314,893)
Change in foreign exchange rates 782     782
Change in fair value of conversion option       (7,200)
Amortization of discount on convertible promissory note       8,000
Changes in operating assets and liabilities:        
Prepaid expenses     (615,932) 219,963
Accrued expenses and accounts payable       158,173
Due to related party       65,427
Deferred liabilities       2,434,861
Net cash used in operating activities     (713,892) (1,910,727)
Cash Flows from Investing Activities:        
Investment held in Trust Account     (265,147,800)  
Net cash used in investing activities     (265,147,800)  
Cash flows from Financing Activities:        
Proceeds from convertible promissory note - related party       1,200,000
Proceeds from Initial Public Offering, net of underwriters' fees     259,844,844  
Proceeds from private placement     8,302,958  
Advances from related parties     150,000  
Payments to related parties     (150,000)  
Payments of offering costs     (992,316)  
Net cash provided by financing activities     267,155,486 1,200,000
Net change in cash     1,293,794 (710,727)
Cash, beginning of the period     0 954,974
Cash, end of the period 244,247 1,293,794 1,293,794 244,247
Supplemental disclosure of noncash investing and financing activities:        
Remeasurement of Class A ordinary shares subject to possible redemption $ 1,173,325     1,545,893
Deferred financing costs included in accrued expenses       426,641
Deferred underwriting commissions charged to additional paid in capital   $ (9,280,173) 9,280,173  
Initial value of Class A ordinary shares subject to possible redemption     265,147,800  
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares     18,106  
Initial classification of warrant liability     $ 23,462,850  
Private warrants issued upon conversion of related party promissory note       480,000
Capital contributed upon settlement of related party note       $ 720,800